Hiba S. Al-Amodi

458 total citations
26 papers, 253 citations indexed

About

Hiba S. Al-Amodi is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Hiba S. Al-Amodi has authored 26 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Hiba S. Al-Amodi's work include Acute Kidney Injury Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Sepsis Diagnosis and Treatment (3 papers). Hiba S. Al-Amodi is often cited by papers focused on Acute Kidney Injury Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Sepsis Diagnosis and Treatment (3 papers). Hiba S. Al-Amodi collaborates with scholars based in Saudi Arabia, Egypt and Sudan. Hiba S. Al-Amodi's co-authors include Hala F. M. Kamel, Safaa Yehia Eid, Mahmoud Zaki El-Readi, Mohammad Althubiti, Christopher McInerny, Chikashi Shimoda, Shuhei Yoshida, Taro Nakamura, Ahmad A. Mirza and Wesam A. Nasif and has published in prestigious journals such as SHILAP Revista de lepidopterología, Genetics and International Journal of Molecular Sciences.

In The Last Decade

Hiba S. Al-Amodi

24 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiba S. Al-Amodi Saudi Arabia 9 122 53 28 26 23 26 253
Miao Xiang China 8 105 0.9× 42 0.8× 23 0.8× 22 0.8× 24 1.0× 19 249
Niraj Babu India 8 128 1.0× 46 0.9× 27 1.0× 16 0.6× 15 0.7× 14 246
Chuncao Xu China 10 169 1.4× 80 1.5× 32 1.1× 35 1.3× 37 1.6× 12 315
Wenbin Xu China 10 113 0.9× 45 0.8× 31 1.1× 19 0.7× 24 1.0× 19 316
Tibor Bielik Slovakia 9 181 1.5× 102 1.9× 61 2.2× 28 1.1× 22 1.0× 10 343
Zheying Tao China 6 123 1.0× 33 0.6× 51 1.8× 26 1.0× 34 1.5× 11 315
Songtao Wu China 12 148 1.2× 62 1.2× 32 1.1× 24 0.9× 14 0.6× 38 351
Yanzhe Liu China 12 147 1.2× 34 0.6× 37 1.3× 23 0.9× 33 1.4× 20 310
Anthony D. Gromovsky United States 7 151 1.2× 72 1.4× 27 1.0× 38 1.5× 12 0.5× 8 280

Countries citing papers authored by Hiba S. Al-Amodi

Since Specialization
Citations

This map shows the geographic impact of Hiba S. Al-Amodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiba S. Al-Amodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiba S. Al-Amodi more than expected).

Fields of papers citing papers by Hiba S. Al-Amodi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiba S. Al-Amodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiba S. Al-Amodi. The network helps show where Hiba S. Al-Amodi may publish in the future.

Co-authorship network of co-authors of Hiba S. Al-Amodi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiba S. Al-Amodi. A scholar is included among the top collaborators of Hiba S. Al-Amodi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiba S. Al-Amodi. Hiba S. Al-Amodi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al-Amodi, Hiba S., et al.. (2025). FCRL1 and BAFF mRNA Expression as Novel Diagnostic and Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma: Expression Signatures Predict R-CHOP Therapy Response and Survival. International Journal of Molecular Sciences. 26(3). 1269–1269. 1 indexed citations
2.
Al-Amodi, Hiba S., Amany Helmy Hasanin, Hala F. M. Kamel, et al.. (2024). Rosavin improves insulin resistance and alleviates hepatic and kidney damage via modulating the cGAS-STING pathway and autophagy signaling in HFD/STZ-induced T2DM animals. RSC Medicinal Chemistry. 15(6). 2098–2113. 5 indexed citations
3.
Al-Amodi, Hiba S., et al.. (2024). Effective Targeting of Glutamine Synthetase with Amino Acid Analogs as a Novel Therapeutic Approach in Breast Cancer. International Journal of Molecular Sciences. 26(1). 78–78. 2 indexed citations
4.
5.
6.
7.
El-Readi, Mahmoud Zaki, Bassem Refaat, Riyad A. Almaimani, et al.. (2023). Antioxidative and Anti-Inflammatory Protective Effects of Fucoxanthin against Paracetamol-Induced Hepatotoxicity in Rats. Marine Drugs. 21(11). 592–592. 9 indexed citations
8.
Babakr, Abdullatif Taha, et al.. (2023). Investigation of Hyperlipidemia Associated with Increased Levels of Oxidized Low-Density Lipoproteins and 8-Hydroxy-2´-Deoxyguanosine. Diabetes Metabolic Syndrome and Obesity. Volume 16. 447–455. 2 indexed citations
9.
10.
11.
12.
Nasif, Wesam A., et al.. (2021). Impact of Helicobacter pylori on hematological parameters among Saudi population. Saudi Medical Journal. 42(6). 643–648. 7 indexed citations
13.
El-Readi, Mahmoud Zaki, Ahmad A. Mirza, Hiba S. Al-Amodi, et al.. (2020). Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2α as a Biomarker of Breast Cancer. Oncology Research and Treatment. 43(10). 506–517. 10 indexed citations
14.
El-Readi, Mahmoud Zaki, Mohammad Althubiti, Hala F. M. Kamel, et al.. (2018). 8-Hydroxy-2’-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer. Clinical Breast Cancer. 19(2). e385–e393. 29 indexed citations
15.
16.
Fatani, Sameer H., et al.. (2018). Testosterone, obesity, and waist circumference as determinants of metabolic syndrome in Saudi women. Diabetes Metabolic Syndrome and Obesity. Volume 11. 175–181. 5 indexed citations
17.
Kamel, Hala F. M. & Hiba S. Al-Amodi. (2017). Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine. Genomics Proteomics & Bioinformatics. 15(4). 220–235. 87 indexed citations
18.
Al-Amodi, Hiba S., et al.. (2017). The effect of obesity and components of metabolic syndrome on leptin levels in Saudi women. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 12(3). 357–364. 11 indexed citations
19.
Saleh, Saleh A. K., et al.. (2017). Variations of Hair Trace Element Contents in Diabetic Females. Journal of Biosciences and Medicines. 5(1). 49–56. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miao Xiang Breakdown of academic impact, for papers by Niraj Babu Breakdown of academic impact, for papers by Chuncao Xu Breakdown of academic impact, for papers by Wenbin Xu Breakdown of academic impact, for papers by Tibor Bielik Breakdown of academic impact, for papers by Zheying Tao Breakdown of academic impact, for papers by Songtao Wu Breakdown of academic impact, for papers by Yanzhe Liu Breakdown of academic impact, for papers by Anthony D. Gromovsky
Rankless by CCL
2026